Skip to main content
. 2018 May 25;1(1):15–21. doi: 10.23922/jarc.2016-004

Table 1.

Clinical Characteristics of Patients with Crohn’s Disease Receiving Post-operative Anti-TNF Antibody Maintenance Therapy.

Variable N=164 (%)
Gender Male 120 (73.2)
Female 44 (26.8)
Age at primary operation (years) 35.5 (range 14-65)
Age at diagnosis ≤40 yrs 149 (90.9)
>40 yrs 15 (9.1)
Disease location Terminalileum 61 (37.2)
Colon 17 (10.4)
Ileum and colon 86 (52.4)
Disease behavior Non-stricturing 4 (2.4)
Stricturing 80 (48.8)
Penetrating 80 (48.8)
Presence of anal lesions Yes 71 (43.3)
No 93 (56.7)
Type of operation Initial surgery 112 (68.3)
Reoperation 52 (31.7)
Ileocecal resection only Yes 16 (90.2)
No 148 (9.8)
Strictureplasty Yes 26 (15.9)
No 138 (84.1)
Post-operative smoking habit Yes 6 (3.7)
No 158 (96.3)
Post-operative thiopurine use Yes 34 (20.7)
No 130 (79.3)
Post-operative elemental diet use Yes 57 (34.8)
No 107 (65.2)